Kallyope

OverviewSuggest Edit

Kallyope is a biotechnology company. It integrates cutting-edge technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology. The company develops a platform that harnesses gut-brain axis.

TypePrivate
Founded2015
HQNew York, NY, US
Websitekallyope.com

Latest Updates

Employees (est.) (Sept 2021)79(+4%)
Cybersecurity ratingAMore

Key People/Management at Kallyope

Nancy Thornberry

Nancy Thornberry

CEO & Director
Ann Weber

Ann Weber

SVP, Preclinical Development
Brett Lauring

Brett Lauring

CMO
Shirly Pinto

Shirly Pinto

SVP, Drug Discovery-Biology
Iyassu Sebhat

Iyassu Sebhat

VP, Chemistry
Juha Lauren

Juha Lauren

CBO
Show more

Kallyope Office Locations

Kallyope has an office in New York
New York, NY, US (HQ)
430 E 29th St
Show all (1)

Kallyope Financials and Metrics

Summary Metrics

Founding Date

2015

Kallyope total Funding

$243 m

Kallyope latest funding size

$112 m

Time since last funding

a year ago

Kallyope investors

Kallyope's latest funding round in March 2020 was reported to be $112 m. In total, Kallyope has raised $243 m
Show all financial metrics

Kallyope Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Kallyope Online and Social Media Presence

Embed Graph

Kallyope News and Updates

Kallyope Inc. Announces $21 Million Expansion of Series B Financing

NEW YORK, Dec. 5, 2018 /PRNewswire/ -- Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced a $21 million expansion of its previously announced Series B financing, bringing the Series B round total to ...

Kallyope Blogs

Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth

Kallyope Inc., a leading biotechnology company focused on identifying and pursuing novel therapeutics involving the gut-brain axis, today announced that the Board of Directors has appointed Jay Galeota as President and he will succeed Nancy Thornberry as Chief Executive Officer by October 1, 2021. M…

Kallyope Inc. Appoints Patrick Flanigan as Chief Financial Officer

Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic opportunities involving the gut-brain axis, today announced that it has appointed Patrick Flanigan to the position of Chief Financial Officer. “We are excited to have Patrick join the Kallyope team as our …

Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis

Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic opportunities involving the gut-brain axis, today announced a $112 million Series C financing.  This financing will be used to advance its portfolio of programs and the company’s first clinical trials, fur…

Kallyope Inc. Appoints Peter Hecht to Board of Directors

Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic opportunities involving the gut-brain axis, today announced that Peter Hecht, Ph.D., CEO of Cyclerion Therapeutics, has been appointed to the company’s Board of Directors. Prior to joining Cyclerion in 201…

Kallyope Inc. Appoints Juha Lauren as Chief Business Officer

Kallyope Inc., a leading biotechnology company focused on identifying and pursuing therapeutic opportunities involving the gut-brain axis, today announced that it has appointed Juha Lauren, M.D., Ph.D., MBA to the position of Chief Business Officer. “We are thrilled to have Juha join the Kallyope te…

Kallyope Inc. Appoints Brett Lauring as Chief Medical Officer

Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced that it has appointed Brett Lauring, M.D., Ph.D. to the position of Chief Medical Officer. “We are thrilled to have Brett join the Kallyope team as our CMO. B…

Kallyope Frequently Asked Questions

  • When was Kallyope founded?

    Kallyope was founded in 2015.

  • Who are Kallyope key executives?

    Kallyope's key executives are Nancy Thornberry, Ann Weber and Brett Lauring.

  • How many employees does Kallyope have?

    Kallyope has 79 employees.

  • Who are Kallyope competitors?

    Competitors of Kallyope include Naked Biome, RealBio Technology and Winnoz Technology.

  • Where is Kallyope headquarters?

    Kallyope headquarters is located at 430 E 29th St, New York.

  • Where are Kallyope offices?

    Kallyope has an office in New York.

  • How many offices does Kallyope have?

    Kallyope has 1 office.